RA Capital wraps third fund at $880M
Venture capital firm RA Capital Management has raised an $880 million fund, its third pool of capital for investment in biotech and pharmaceutical companies.
The Boston-based firm says it will use a multi-stage approach, including new company formation, public equity and traditional venture financing — although RA Capital did not specify what stages it plans to target. This fund in particular will go largely toward investments in private companies. “As a multistage fund, we have the ability…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Rowan Walrath Source Type: news